A groundbreaking procedure by UTMB’s Chairman of Radiology Dr. Eric Walser
A new non-surgical prostate cancer treatment offered at the University of Texas Medical Branch virtually eliminates the side effects of impotence and incontinence that can occur when patients receive the traditional treatment for prostate cancer – surgical prostate removal.
UTMB’s Chairman of Radiology Dr. Eric Walser is one of only a few physicians in the world and the only physician in Texas who performs this groundbreaking procedure. Using a state-of-the-art, MRI-guided laser ablation instrument developed at UTMB, he zaps away the cancer without removing the prostate.
With national standards for prostate cancer screening changing so dramatically over the past year, many men are confused about what it means to have prostate cancer, whether they should be tested for it and what they should do if they test positive.
The American Urological Association’s new prostate cancer screening guidelines say that men under 55 should no longer receive routine prostate screening and that men over 80 should not receive it if they have a life expectancy less than 10 to 15 years. The association determined the odds of preventing prostate cancer death with a PSA (prostate specific antigen) blood test for men ages 55 to 69 amounted to one life spared for every 1,000 men screened over a decade.
This is on the heels of the U.S. Preventive Services Task Force’s statement last May, saying that much more harm than good was being done to men who underwent screening, biopsy and surgical removal of their prostate gland. The vast majority of prostate cancers are so slow-growing that they will never cause a problem. On the other hand, the impotence and incontinence that can result when the sensitive nerves surrounding the prostate are damaged or severed during surgery can be devastating.
The gist of all this is that the standard treatment — surgical prostate removal — causes more damage than the disease ever would have.
“The problem is, most men who test positive, even if the risk is one in 1,000 of dying of prostate cancer,” said Walser, “still just want to get it out of there. You never know if you are going to be that one.”
In the past, there was no way for doctors to remove prostate cancer without removing the whole prostate gland. This is because the available imaging technology was not powerful enough to illuminate the cancer and the available laser ablation technology was not focused enough to remove the cancer without damaging surrounding tissue. But in recent years, the technology has improved significantly.
“Our approach pairs the most advanced MRI imaging to pinpoint the precise location of cancer in the prostate and the most advanced laser technology to remove it completely, with virtually no risk of impotence or incontinence,” said Walser.
Walser, who has been performing this procedure for three years, says this new way of treating prostate cancer offers men much more peace of mind than active surveillance or “watchful waiting,” the traditional alternative to radical treatment.
NIH-funded clinical trials of this new procedure so far show that it is safe and effective, with results from Phase 1 just published online in the journal Radiology and Phase 2 currently being conducted at the University of Chicago Medicine.